Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 31 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2024 Filed Mar 18, 2024 21:48 UTC |
Azelby RobertDirector
|
GrantCommon Shares | 1,288 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-24-000019 · wk-form4_1710798486.xml · nonDerivative · entry 1 Azelby Robert · CIK 0001656998 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,288 F1 · shares: Grant of restricted share units that will vest on March 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 13:55 UTC |
Alt Aaron EChief Financial Officer
|
Tax withholdingCommon Shares | 1,919 | $103.55 | $198,712.45 |
DisclosureSEC source: 0000721371-24-000009 · wk-form4_1708091710.xml · nonDerivative · entry 1 Alt Aaron E · CIK 0001741576 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,400 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 4,242 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 13:51 UTC |
Greene Michelle D.Chief Information Officer
|
Tax withholdingCommon Shares | 664 | $103.55 | $68,757.20 |
DisclosureSEC source: 0000721371-24-000007 · wk-form4_1708091464.xml · nonDerivative · entry 1 Greene Michelle D. · CIK 0001945228 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,150 F1 · shares: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,401 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:46 UTC |
Snow Ola MChief Human Resources Officer
|
Tax withholdingCommon Shares | 382 | $107.08 | $40,904.56 |
DisclosureSEC source: 0000721371-23-000118 · wk-form4_1701812798.xml · nonDerivative · entry 1 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,842 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:44 UTC |
Scherer Mary C.Chief Accounting Officer
|
Tax withholdingCommon Shares | 217 | $107.08 | $23,236.36 |
DisclosureSEC source: 0000721371-23-000116 · wk-form4_1701812684.xml · nonDerivative · entry 1 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,432 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:42 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 638 | $107.08 | $68,317.04 |
DisclosureSEC source: 0000721371-23-000114 · wk-form4_1701812542.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,564 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,373 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · derivative · entry 7 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 15,373 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2018, August 15, 2019, and August 15, 2020. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,279 | $0.00 Strike: $83.19 | $0.00 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · derivative · entry 6 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,279 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2017, August 15, 2018, and August 15, 2019. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,990 | $0.00 Strike: $84.27 | $0.00 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · derivative · entry 5 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,990 shares Expires 2025-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2016, August 15, 2017, and August 15, 2018. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
SaleCommon Shares | 36,642 | $106.31 | $3,895,411.02 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 4 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,202 F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.11 to $106.76, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionCommon Shares | 15,373 | $66.43 | $1,021,228.39 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 3 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionCommon Shares | 6,279 | $83.19 | $522,350.01 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:14 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionCommon Shares | 5,990 | $84.27 | $504,777.30 |
DisclosureSEC source: 0000721371-23-000112 · wk-form4_1701267277.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2023. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:32 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Tax withholdingCommon Shares | 5,185 | $102.90 | $533,536.50 |
DisclosureSEC source: 0000721371-23-000110 · wk-form4_1700170314.xml · nonDerivative · entry 1 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,680 F1 · shares: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 11,560 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:31 UTC |
Brennan MichelleDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000109 · wk-form4_1700170251.xml · nonDerivative · entry 1 Brennan Michelle · CIK 0001827353 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,289 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:30 UTC |
Barg StevenDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000108 · wk-form4_1700170191.xml · nonDerivative · entry 1 Barg Steven · CIK 0001852883 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,739 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:29 UTC |
Hall Patricia HemingwayDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000107 · wk-form4_1700170120.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,467 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:27 UTC |
Chandrasekaran SujathaDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000106 · wk-form4_1700170053.xml · nonDerivative · entry 1 Chandrasekaran Sujatha · CIK 0001734598 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,739 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:26 UTC |
MUNDKUR CHRISTINEDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000105 · wk-form4_1700169981.xml · nonDerivative · entry 1 MUNDKUR CHRISTINE · CIK 0001237264 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,739 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:25 UTC |
Killefer NancyDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000104 · wk-form4_1700169933.xml · nonDerivative · entry 1 Killefer Nancy · CIK 0001584637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,827 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:24 UTC |
JOHRI AKHILDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000103 · wk-form4_1700169872.xml · nonDerivative · entry 1 JOHRI AKHIL · CIK 0001517450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,071 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:23 UTC |
KENNY GREGORY BDirector
|
GrantCommon Shares | 3,193 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000102 · wk-form4_1700169813.xml · nonDerivative · entry 1 KENNY GREGORY B · CIK 0001179497 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,680 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:22 UTC |
Evans David CDirector
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000101 · wk-form4_1700169770.xml · nonDerivative · entry 1 Evans David C · CIK 0001375909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,576 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:22 UTC |
Edison Sheri H.Director
|
GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000100 · wk-form4_1700169714.xml · nonDerivative · entry 1 Edison Sheri H. · CIK 0001413612 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,051 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| August 28, 2023 Filed Aug 29, 2023 20:21 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,712 | $0.00 Strike: $71.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000082 · wf-form4_169334045113732.xml · derivative · entry 3 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,712 shares Expires 2024-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2015, August 15, 2016, and August 15, 2017. Read SEC document |
| August 28, 2023 Filed Aug 29, 2023 20:21 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
SaleCommon Shares | 6,712 | $89.81 | $602,804.72 |
DisclosureSEC source: 0000721371-23-000082 · wf-form4_169334045113732.xml · nonDerivative · entry 2 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,202 Read SEC document |
| August 28, 2023 Filed Aug 29, 2023 20:21 UTC |
WEITZMAN DEBORAHCEO, Pharmaceutical Segment
|
Exercise / conversionCommon Shares | 6,712 | $71.43 | $479,438.16 |
DisclosureSEC source: 0000721371-23-000082 · wf-form4_169334045113732.xml · nonDerivative · entry 1 WEITZMAN DEBORAH · CIK 0001942639 · CEO, Pharmaceutical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,551 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · derivative · entry 9 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,551 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2018, August 15, 2019, and August 15, 2020. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,616 | $0.00 Strike: $83.19 | $0.00 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · derivative · entry 8 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,616 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2017, August 15, 2018, and August 15, 2019. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,496 | $0.00 Strike: $84.27 | $0.00 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · derivative · entry 7 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,496 shares Expires 2025-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2016, August 15, 2017, and August 15, 2018. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,797 | $0.00 Strike: $71.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · derivative · entry 6 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,797 shares Expires 2024-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2015, August 15, 2016, and August 15, 2017. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
SaleCommon Shares | 20,695 | $86.27 | $1,785,357.65 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · nonDerivative · entry 5 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,649 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.10 to $86.53, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionCommon Shares | 3,551 | $66.43 | $235,892.93 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · nonDerivative · entry 4 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionCommon Shares | 2,616 | $83.19 | $217,625.04 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · nonDerivative · entry 3 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionCommon Shares | 2,496 | $84.27 | $210,337.92 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · nonDerivative · entry 2 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:16 UTC |
Scherer Mary C.Chief Accounting Officer
|
Exercise / conversionCommon Shares | 2,797 | $71.43 | $199,789.71 |
DisclosureSEC source: 0000721371-23-000080 · wf-form4_169264898545529.xml · nonDerivative · entry 1 Scherer Mary C. · CIK 0001945352 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
SaleCommon Shares | 10,668 | $87.68 | $935,370.24 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · nonDerivative · entry 6 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,865 F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.53 to $87.86, inclusive. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:52 UTC |
Mason Stephen MCEO, Medical Segment
|
SaleCommon Shares | 7,977 | $88.42 | $705,326.34 |
DisclosureSEC source: 0000721371-23-000072 · wf-form4_169231635388699.xml · nonDerivative · entry 5 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,355 F6 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.92 to $88.69, inclusive. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:52 UTC |
Mason Stephen MCEO, Medical Segment
|
SaleCommon Shares | 18,528 | $87.40 | $1,619,347.20 |
DisclosureSEC source: 0000721371-23-000072 · wf-form4_169231635388699.xml · nonDerivative · entry 4 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,332 F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.92 to $87.90, inclusive. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:52 UTC |
Mason Stephen MCEO, Medical Segment
|
SaleCommon Shares | 10,995 | $86.40 | $949,968.00 |
DisclosureSEC source: 0000721371-23-000072 · wf-form4_169231635388699.xml · nonDerivative · entry 3 Mason Stephen M · CIK 0001786065 · CEO, Medical Segment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,860 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.93 to $86.90, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:49 UTC |
Greene Michelle D.Chief Information Officer
|
SaleCommon Shares | 2,000 | $86.79 | $173,580.00 |
DisclosureSEC source: 0000721371-23-000068 · wf-form4_169231616625890.xml · nonDerivative · entry 3 Greene Michelle D. · CIK 0001945228 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,814 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.65 to $86.92, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:47 UTC |
Snow Ola MChief Human Resources Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,907 | $0.00 Strike: $71.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000066 · wf-form4_169231603006162.xml · derivative · entry 8 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,907 shares Expires 2024-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2014, August 15, 2015, and August 15, 2016. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:47 UTC |
Snow Ola MChief Human Resources Officer
|
GiftCommon Shares | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000066 · wf-form4_169231603006162.xml · nonDerivative · entry 6 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,224 Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:47 UTC |
Snow Ola MChief Human Resources Officer
|
SaleCommon Shares | 131 | $87.96 | $11,522.76 |
DisclosureSEC source: 0000721371-23-000066 · wf-form4_169231603006162.xml · nonDerivative · entry 5 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,762 Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:47 UTC |
Snow Ola MChief Human Resources Officer
|
SaleCommon Shares | 26,193 | $87.41 | $2,289,530.13 |
DisclosureSEC source: 0000721371-23-000066 · wf-form4_169231603006162.xml · nonDerivative · entry 4 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,893 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.87 to $87.86, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4. Read SEC document |
| August 17, 2023 Filed Aug 17, 2023 23:47 UTC |
Snow Ola MChief Human Resources Officer
|
Exercise / conversionCommon Shares | 3,907 | $71.43 | $279,077.01 |
DisclosureSEC source: 0000721371-23-000066 · wf-form4_169231603006162.xml · nonDerivative · entry 3 Snow Ola M · CIK 0001754463 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 973 | $0.00 Strike: $84.27 | $0.00 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · derivative · entry 8 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 973 shares Expires 2025-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2015, August 15, 2016, and August 15, 2017. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,142 | $0.00 Strike: $71.43 | $0.00 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · derivative · entry 7 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,142 shares Expires 2024-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Stock option vested in three equal installments on August 15, 2014, August 15, 2015, and August 15, 2016. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
SaleCommon Shares | 30,145 | $90.84 | $2,738,371.80 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · nonDerivative · entry 5 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,533 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.64 to $91.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 23:57 UTC |
Mayer Jessica LChief Legal/Compliance Officer
|
Exercise / conversionCommon Shares | 973 | $84.27 | $81,994.71 |
DisclosureSEC source: 0000721371-23-000078 · wf-form4_169231666604167.xml · nonDerivative · entry 4 Mayer Jessica L · CIK 0001771383 · Chief Legal/Compliance Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.